Zobrazeno 1 - 10
of 301
pro vyhledávání: '"Citron MP"'
Autor:
Nussbaum J; Merck & Co., Inc., Rahway, NJ, USA. Electronic address: jesse.nussbaum@merck.com., Cao X; Merck & Co., Inc., Rahway, NJ, USA., Railkar RA; Merck & Co., Inc., Rahway, NJ, USA., Sachs JR; Merck & Co., Inc., Rahway, NJ, USA., Spellman DS; Merck & Co., Inc., Rahway, NJ, USA., Luk J; Merck & Co., Inc., Rahway, NJ, USA., Shaw CA; Moderna Inc., Cambridge, MA, USA., Cejas PJ; Merck & Co., Inc., Rahway, NJ, USA., Citron MP; Merck & Co., Inc., Rahway, NJ, USA., Al-Ibrahim M; Pharmaron, Baltimore, MD, USA., Han D; Parexel, Glendale, CA, USA., Pagnussat S; QPS, Miami, FL, USA., Stoch SA; Merck & Co., Inc., Rahway, NJ, USA., Lai E; Merck & Co., Inc., Rahway, NJ, USA., Bett AJ; Merck & Co., Inc., Rahway, NJ, USA., Espeseth AS; Merck & Co., Inc., Rahway, NJ, USA.
Publikováno v:
Vaccine [Vaccine] 2023 Oct 20; Vol. 41 (44), pp. 6488-6501. Date of Electronic Publication: 2023 Sep 29.
Autor:
Flynn JA; Merck & Co., Inc., Kenilworth, NJ, USA. Electronic address: jessica_flynn@merck.com., Weber T; Merck & Co., Inc., Kenilworth, NJ, USA., Cejas PJ; Spark Therapeutics, Inc, USA(1)., Cox KS; Merck & Co., Inc., Kenilworth, NJ, USA., Touch S; Merck & Co., Inc., Kenilworth, NJ, USA., Austin LA; Merck & Co., Inc., Kenilworth, NJ, USA., Ou Y; Merck & Co., Inc., Kenilworth, NJ, USA., Citron MP; Merck & Co., Inc., Kenilworth, NJ, USA., Luo B; Merck & Co., Inc., Kenilworth, NJ, USA., Gindy ME; Merck & Co., Inc., Kenilworth, NJ, USA., Bahl K; Moderna, Inc., Cambridge, MA, USA., Ciaramella G; Beam Therapeutics, USA(1)., Espeseth AS; Merck & Co., Inc., Kenilworth, NJ, USA., Zhang L; Merck & Co., Inc., Kenilworth, NJ, USA. Electronic address: lan_zhang2@merck.com.
Publikováno v:
Vaccine [Vaccine] 2022 Jul 30; Vol. 40 (32), pp. 4412-4423. Date of Electronic Publication: 2022 Jun 06.
Autor:
Zohar T; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Hsiao JC; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Mehta N; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA., Das J; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA., Devadhasan A; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA., Karpinski W; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA., Callahan C; Merck & Co., Inc., Kenilworth, NJ 07033, USA., Citron MP; Merck & Co., Inc., Kenilworth, NJ 07033, USA., DiStefano DJ; Merck & Co., Inc., Kenilworth, NJ 07033, USA., Touch S; Merck & Co., Inc., Kenilworth, NJ 07033, USA., Wen Z; Merck & Co., Inc., Kenilworth, NJ 07033, USA., Sachs JR; Merck & Co., Inc., Kenilworth, NJ 07033, USA., Cejas PJ; Merck & Co., Inc., Kenilworth, NJ 07033, USA., Espeseth AS; Merck & Co., Inc., Kenilworth, NJ 07033, USA., Lauffenburger DA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Bett AJ; Merck & Co., Inc., Kenilworth, NJ 07033, USA. Electronic address: andrew_bett@merck.com., Alter G; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA. Electronic address: galter@mgh.harvard.edu.
Publikováno v:
Cell host & microbe [Cell Host Microbe] 2022 Jan 12; Vol. 30 (1), pp. 41-52.e5. Date of Electronic Publication: 2021 Dec 07.
Autor:
Citron MP; Infectious Disease & Vaccines, Merck & Co., Inc., Kenilworth, NJ 07033, USA., McAnulty J; Infectious Disease & Vaccines, Merck & Co., Inc., Kenilworth, NJ 07033, USA., Callahan C; Infectious Disease & Vaccines, Merck & Co., Inc., Kenilworth, NJ 07033, USA., Knapp W; Safety Assessment and Laboratory Animal Resources, Merck & Co., Inc., Kenilworth, NJ 07033, USA., Fontenot J; The New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA 70560, USA., Morales P; The Mannheimer Foundation, Homestead, FL 33034, USA., Flynn JA; Infectious Disease & Vaccines, Merck & Co., Inc., Kenilworth, NJ 07033, USA., Douglas CM; Infectious Disease & Vaccines, Merck & Co., Inc., Kenilworth, NJ 07033, USA., Espeseth AS; Infectious Disease & Vaccines, Merck & Co., Inc., Kenilworth, NJ 07033, USA.
Publikováno v:
Pathogens (Basel, Switzerland) [Pathogens] 2021 Nov 05; Vol. 10 (11). Date of Electronic Publication: 2021 Nov 05.
Autor:
Espeseth AS; 1ID/Vaccines Discovery, Merck & Co., Inc., Kenilworth, NJ USA., Cejas PJ; 1ID/Vaccines Discovery, Merck & Co., Inc., Kenilworth, NJ USA., Citron MP; 1ID/Vaccines Discovery, Merck & Co., Inc., Kenilworth, NJ USA., Wang D; 1ID/Vaccines Discovery, Merck & Co., Inc., Kenilworth, NJ USA., DiStefano DJ; 1ID/Vaccines Discovery, Merck & Co., Inc., Kenilworth, NJ USA., Callahan C; 1ID/Vaccines Discovery, Merck & Co., Inc., Kenilworth, NJ USA., Donnell GO; 2Pharmacology, Merck & Co., Inc., Kenilworth, NJ USA., Galli JD; 1ID/Vaccines Discovery, Merck & Co., Inc., Kenilworth, NJ USA., Swoyer R; 1ID/Vaccines Discovery, Merck & Co., Inc., Kenilworth, NJ USA., Touch S; 1ID/Vaccines Discovery, Merck & Co., Inc., Kenilworth, NJ USA., Wen Z; 1ID/Vaccines Discovery, Merck & Co., Inc., Kenilworth, NJ USA., Antonello J; 3Biostatistics, Merck & Co., Inc., Kenilworth, NJ USA., Zhang L; 1ID/Vaccines Discovery, Merck & Co., Inc., Kenilworth, NJ USA., Flynn JA; 1ID/Vaccines Discovery, Merck & Co., Inc., Kenilworth, NJ USA., Cox KS; 1ID/Vaccines Discovery, Merck & Co., Inc., Kenilworth, NJ USA., Freed DC; 1ID/Vaccines Discovery, Merck & Co., Inc., Kenilworth, NJ USA., Vora KA; 1ID/Vaccines Discovery, Merck & Co., Inc., Kenilworth, NJ USA., Bahl K; Moderna, Inc., Cambridge, MA USA., Latham AH; 5Pharmaceutical Science, Merck & Co., Inc., Kenilworth, NJ USA., Smith JS; 5Pharmaceutical Science, Merck & Co., Inc., Kenilworth, NJ USA., Gindy ME; 5Pharmaceutical Science, Merck & Co., Inc., Kenilworth, NJ USA., Ciaramella G; Moderna, Inc., Cambridge, MA USA., Hazuda D; 1ID/Vaccines Discovery, Merck & Co., Inc., Kenilworth, NJ USA., Shaw CA; Moderna, Inc., Cambridge, MA USA., Bett AJ; 1ID/Vaccines Discovery, Merck & Co., Inc., Kenilworth, NJ USA.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2020 Feb 14; Vol. 5 (1), pp. 16. Date of Electronic Publication: 2020 Feb 14 (Print Publication: 2020).
Autor:
Tang A; Department of Infectious Diseases and Vaccines Research, Merck & Co., Inc, West Point, PA, USA., Chen Z; Department of Infectious Diseases and Vaccines Research, Merck & Co., Inc, West Point, PA, USA., Cox KS; Department of Infectious Diseases and Vaccines Research, Merck & Co., Inc, West Point, PA, USA., Su HP; Department of Structural Chemistry and Chemical Biotechnology, Merck & Co., Inc, West Point, PA, USA., Callahan C; Department of Infectious Diseases and Vaccines Research, Merck & Co., Inc, West Point, PA, USA., Fridman A; Department of Scientific Informatics, Merck & Co., Inc., Rahway, NJ, USA., Zhang L; Department of Infectious Diseases and Vaccines Research, Merck & Co., Inc, West Point, PA, USA., Patel SB; Department of Structural Chemistry and Chemical Biotechnology, Merck & Co., Inc, West Point, PA, USA., Cejas PJ; Department of Infectious Diseases and Vaccines Research, Merck & Co., Inc, West Point, PA, USA., Swoyer R; Department of Infectious Diseases and Vaccines Research, Merck & Co., Inc, West Point, PA, USA., Touch S; Department of Infectious Diseases and Vaccines Research, Merck & Co., Inc, West Point, PA, USA., Citron MP; Department of Infectious Diseases and Vaccines Research, Merck & Co., Inc, West Point, PA, USA., Govindarajan D; Department of Infectious Diseases and Vaccines Research, Merck & Co., Inc, West Point, PA, USA.; Janssen Research & Development, 1400 McKean Road, Ambler, PA, 19002, USA., Luo B; Department of Pharmacology, Merck & Co., Inc., West Point, PA, USA., Eddins M; Department of Structural Chemistry and Chemical Biotechnology, Merck & Co., Inc, West Point, PA, USA., Reid JC; Department of Structural Chemistry and Chemical Biotechnology, Merck & Co., Inc, West Point, PA, USA., Soisson SM; Department of Structural Chemistry and Chemical Biotechnology, Merck & Co., Inc, West Point, PA, USA., Galli J; Department of Infectious Diseases and Vaccines Research, Merck & Co., Inc, West Point, PA, USA., Wang D; Department of Infectious Diseases and Vaccines Research, Merck & Co., Inc, West Point, PA, USA., Wen Z; Department of Infectious Diseases and Vaccines Research, Merck & Co., Inc, West Point, PA, USA., Heidecker GJ; Department of Infectious Diseases and Vaccines Research, Merck & Co., Inc, West Point, PA, USA., Casimiro DR; Department of Infectious Diseases and Vaccines Research, Merck & Co., Inc, West Point, PA, USA.; Sanofi Pasteur, 1 Discovery Drive, Swiftwater, PA, 18370, USA., DiStefano DJ; Department of Infectious Diseases and Vaccines Research, Merck & Co., Inc, West Point, PA, USA., Vora KA; Department of Infectious Diseases and Vaccines Research, Merck & Co., Inc, West Point, PA, USA. kalpit.vora@merck.com.
Publikováno v:
Nature communications [Nat Commun] 2019 Sep 12; Vol. 10 (1), pp. 4153. Date of Electronic Publication: 2019 Sep 12.
Autor:
Citron MP; Infectious Disease/Vaccines, Merck & Co., Inc., Kenilworth, NJ 07033, United States. Electronic address: michael_citron@merck.com., Patel M; Translational Imaging Biomarkers, Merck & Co., Inc., Kenilworth, NJ 07033, United States., Purcell M; Translational Imaging Biomarkers, Merck & Co., Inc., Kenilworth, NJ 07033, United States., Lin SA; Translational Imaging Biomarkers, Merck & Co., Inc., Kenilworth, NJ 07033, United States., Rubins DJ; Translational Imaging Biomarkers, Merck & Co., Inc., Kenilworth, NJ 07033, United States., McQuade P; Translational Imaging Biomarkers, Merck & Co., Inc., Kenilworth, NJ 07033, United States., Callahan C; Infectious Disease/Vaccines, Merck & Co., Inc., Kenilworth, NJ 07033, United States., Gleason A; Translational Imaging Biomarkers, Merck & Co., Inc., Kenilworth, NJ 07033, United States., Petrescu I; Safety Assessment and Laboratory Animal Sciences, Merck & Co., Inc., Kenilworth, NJ 07033, United States., Knapp W; Safety Assessment and Laboratory Animal Sciences, Merck & Co., Inc., Kenilworth, NJ 07033, United States., Orekie C; Biopharmaceutics & Specialty DF/Development, Merck & Co., Inc., Kenilworth, NJ 07033, United States., Chamarthy S; Biopharmaceutics & Specialty DF/Development, Merck & Co., Inc., Kenilworth, NJ 07033, United States., Wen Z; Infectious Disease/Vaccines, Merck & Co., Inc., Kenilworth, NJ 07033, United States., Touch S; Infectious Disease/Vaccines, Merck & Co., Inc., Kenilworth, NJ 07033, United States., Pine M; Infectious Disease/Vaccines, Merck & Co., Inc., Kenilworth, NJ 07033, United States., Fontenot J; The University of Louisiana New Iberia Research Center, New Iberia, LA 70560, United States., Douglas C; Infectious Disease/Vaccines, Merck & Co., Inc., Kenilworth, NJ 07033, United States., Liang X; Infectious Disease/Vaccines, Merck & Co., Inc., Kenilworth, NJ 07033, United States., Espeseth AS; Infectious Disease/Vaccines, Merck & Co., Inc., Kenilworth, NJ 07033, United States.
Publikováno v:
Vaccine [Vaccine] 2018 May 11; Vol. 36 (20), pp. 2876-2885. Date of Electronic Publication: 2018 Mar 26.
Autor:
Wang D; Department of Infectious Diseases and Vaccines, Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA dai_wang@merck.com., Phan S; Department of Infectious Diseases, University of Georgia, Athens, Georgia, USA., DiStefano DJ; Department of Infectious Diseases and Vaccines, Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., Citron MP; Department of Infectious Diseases and Vaccines, Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., Callahan CL; Department of Infectious Diseases and Vaccines, Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., Indrawati L; Department of Infectious Diseases and Vaccines, Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., Dubey SA; Department of Infectious Diseases and Vaccines, Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., Heidecker GJ; Department of Infectious Diseases and Vaccines, Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., Govindarajan D; Department of Infectious Diseases and Vaccines, Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., Liang X; Department of Infectious Diseases and Vaccines, Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA., He B; Department of Infectious Diseases, University of Georgia, Athens, Georgia, USA., Espeseth AS; Department of Infectious Diseases and Vaccines, Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA.
Publikováno v:
Journal of virology [J Virol] 2017 May 12; Vol. 91 (11). Date of Electronic Publication: 2017 May 12 (Print Publication: 2017).
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.